Atrial Fibrillation is an Independent Predictor for In-hospital Mortality in Patients Admitted with SARS-CoV-2 Infection

Atrial Fibrillation

In-hospital mortality of patients with atrial arrhythmias: insights from the German-wide Helios hospital network of 161 502 patients and 34 025 arrhythmia-related procedures

Eur Heart J.

König S, Ueberham L, Schuler E, Wiedemann M, Reithmann C, Seyfarth M, Sause A, Tebbenjohanns J, Schade A, Shin D, Staudt A, Zacharzowsky U, Andrié R, Wetzel U, Neuser H, Wunderlich C, Kuhlen R, Tijssen JGP, Hindricks G, Bollmann A

doi: 10.1093/eurheartj/ehy528.

Atrial FibrillationHeart Failure

Type 2 diabetes increases the long-term risk of heart failure and mortality in patients with atrial fibrillation

Eur J Heart Fail.

Polovina M, Lund LH, Đikić D, Petrović-Đorđević I, Krljanac G, Milinković I, Veljić I, Piepoli MF, Rosano GMC, Ristić AD, Ašanin M, Seferović PM

doi: 10.1002/ejhf.1666.

Cardiovascular Risk and DiseasesAtrial FibrillationHeart FailureThrombosis and Stroke

Digoxin and Mortality in Patients With Atrial Fibrillation

J Am Coll Cardiol.

Lopes RD, Rordorf R, De Ferrari GM, Leonardi S, Thomas L, Wojdyla DM, Ridefelt P, Lawrence JH, De Caterina R, Vinereanu D, Hanna M, Flaker G, Al-Khatib SM, Hohnloser SH, Alexander JH, Granger CB, Wallentin L

doi: 10.1016/j.jacc.2017.12.060.

Atrial FibrillationHeart Failure

Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation: An AF-CHF Substudy.

JACC Heart Fail.

Cadrin-Tourigny J, Shohoudi A, Roy D, Talajic M, Tadros R, Mondésert B, Dyrda K, Rivard L, Andrade JG, Macle L, Guerra PG, Thibault B, Dubuc M, Khairy P

doi: 10.1016/j.jchf.2016.10.015.

Heart Failure

Increased susceptibility to SARS-CoV-2 infection in patients with reduced left ventricular ejection fraction

ESC Heart Fail

Matsushita K, Marchandot B, Carmona A, Curtiaud A, El Idrissi A, Trimaille A, Kibler M, Cardi T, Heger J, Hess S, Reydel A, Jesel L, Ohlmann P, Morel O

doi: 10.1002/ehf2.13083

Atrial Fibrillation

Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial

JAMA.

Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, Noseworthy PA, Rosenberg YD, Jeffries N, Mitchell LB, Flaker GC, Pokushalov E, Romanov A, Bunch TJ, Noelker G, Ardashev A, Revishvili A, Wilber DJ, Cappato R, Kuck KH, Hindricks G, Davies DW, Kowey PR, Naccarelli GV, Reiffel JA, Piccini JP, Silverstein AP, Al-Khalidi HR, Lee KL, CABANA Investigators

doi: 10.1001/jama.

Atrial FibrillationThrombosis and StrokeTherapy and Intervention

Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft Surgery and Patients With Nonvalvular Atrial Fibrillation

JAMA Cardiol.

Butt JH, Xian Y, Peterson ED, Olsen PS, Rørth R, Gundlund A, Olesen JB, Gislason GH, Torp-Pedersen C, Køber L, Fosbøl EL

doi: 10.1001/jamacardio.

Atrial FibrillationHeart Failure

Risk model for predicting complications in patients undergoing atrial fibrillation ablation

Heart Rhythm.

Padala SK, Gunda S, Sharma PS, Kang L, Koneru JN, Ellenbogen KA

doi: 10.1016/j.hrthm.2017.04.042.

Atrial FibrillationTherapy and Intervention

Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.

Circulation

Gibson CM, Pinto DS, Chi G, Arbetter D, Yee M, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, Burton P, van Eickels M, Korjian S, Daaboul Y, Jain P, Lip GY, Cohen M, Peterson ED, Fox KA

doi: 10.1161/CIRCULATION

Related content

In-hospital mortality of patients with atrial arrhythmias: insights from the German-wide Helios hospital network of 161 502 patients and 34 025 arrhythmia-related procedures

Type 2 diabetes increases the long-term risk of heart failure and mortality in patients with atrial fibrillation

Digoxin and Mortality in Patients With Atrial Fibrillation

Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation: An AF-CHF Substudy.

Increased susceptibility to SARS-CoV-2 infection in patients with reduced left ventricular ejection fraction

Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial

Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft Surgery and Patients With Nonvalvular Atrial Fibrillation

Risk model for predicting complications in patients undergoing atrial fibrillation ablation

Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.